This study evaluates the epicutaneous immunogenicity of partially hydrolyzed whey protein; results show that PWH1 and PWH2 did not induce significant sensitization or anaphylaxis, indicating low allergenic risk.
This study investigates the inhibitory effect of whey protein hydrolysates on epicutaneous sensitization to β-lactoglobulin, not confirming the sensitization risk of whey protein itself; results show that partially hydrolyzed whey protein prevents sensitization, indicating low allergenicity.
05
光毒性
2 条
评估报告结论2
报告结论光毒性数据不足
无光毒性数据。
美国 CIR 专家组安全评估报告|Safety Assessment of Bovine Milk Proteins and Protein Derivatives as Used in Cosmetics. IJT 41(Suppl. 2):43-56, 2022
报告结论光毒性数据不足
无光毒性数据。
美国 CIR 专家组安全评估报告|Safety Assessment of Milk Proteins and Protein Derivatives as Used in Cosmetics
以上为评估报告对该终点的结论摘录(报告级),非单次实验记录;逐条标注来源报告,本平台不作再评价。
06
致痘性
2 条
评估报告结论2
报告结论致痘性(致粉刺性)数据不足
无致粉刺性数据。
美国 CIR 专家组安全评估报告|Safety Assessment of Bovine Milk Proteins and Protein Derivatives as Used in Cosmetics. IJT 41(Suppl. 2):43-56, 2022
报告结论致痘性(致粉刺性)数据不足
无致粉刺性数据。
美国 CIR 专家组安全评估报告|Safety Assessment of Milk Proteins and Protein Derivatives as Used in Cosmetics
以上为评估报告对该终点的结论摘录(报告级),非单次实验记录;逐条标注来源报告,本平台不作再评价。
07
生殖毒性与孕期使用
3 条
评估报告结论2
报告结论生殖毒性数据不足
无生殖毒性数据。
美国 CIR 专家组安全评估报告|Safety Assessment of Bovine Milk Proteins and Protein Derivatives as Used in Cosmetics. IJT 41(Suppl. 2):43-56, 2022
报告结论生殖毒性数据不足
无生殖毒性数据。
美国 CIR 专家组安全评估报告|Safety Assessment of Milk Proteins and Protein Derivatives as Used in Cosmetics
This study investigates whey protein encapsulation of cinnamon essential oil for protection against mycotoxin toxicity; whey protein is only used as wall material and not studied for reproductive toxicity; whey protein itself showed no toxic effects, no relevance to pregnancy risk.
08
其他毒性终点
7 条
以下终点(致癌性、遗传毒性、急性毒性等)属系统毒理学评估范畴,无对应的化妆品使用场景文献指标。
评估报告结论4
报告结论遗传毒性数据不足
无遗传毒性数据。
美国 CIR 专家组安全评估报告|Safety Assessment of Bovine Milk Proteins and Protein Derivatives as Used in Cosmetics. IJT 41(Suppl. 2):43-56, 2022